Skip to main content
SpringerLink
Log in

Acute and Chronic Lung Disease from Recreational Inhalants

  • Chapter
  • First Online:
Lung Health and the Exposome

Part of the book series: Respiratory Medicine ((RM))

  • 432 Accesses

Abstract

The use of recreational inhalants is exceedingly common in the United States with over 14% of Americans reporting that they have ever tried electronic (e-)cigarettes alone. The prevalence of recreational inhalant use has been increasing in the adolescent and young adult population raising concerns about the potential long-term public health consequences. While data is still emerging about the effects of newer recreational inhalants, such as e-cigarettes, it is clear that the use of inhalants comes with a cost. This chapter will discuss the potential complications of recreational inhalants as it relates to lung health, specifically reviewing pulmonary disease secondary to the use of e-cigarettes, marijuana, hookah, cocaine, methamphetamines, and other common illicit and commercial inhalants. Both acute and chronic complications of these recreational inhalants will be discussed, including the recent epidemic of e-cigarette or vaping product use-associated lung injury (EVALI). Where known, the mechanisms leading to lung injury will be reviewed. Finally, given an overall paucity of large studies examining the pulmonary consequences of illicit and commercial recreational inhalants, areas for future research will be highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control. 2014;23 Suppl 3:iii3-9.

    PubMed  Google Scholar 

  2. Theron AJ, Feldman C, Richards GA, Tintinger GR, Anderson R. Electronic cigarettes: where to from here? J Thorac Dis. 2019;11(12):5572–85.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dinakar C, O’Connor GT. The health effects of electronic cigarettes. N Engl J Med. 2016;375(14):1372–81.

    Article  PubMed  Google Scholar 

  4. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23 Suppl 2:ii11-7.

    PubMed  Google Scholar 

  5. Goniewicz ML, Boykan R, Messina CR, Eliscu A, Tolentino J. High exposure to nicotine among adolescents who use Juul and other vape pod systems (‘pods’). Tob Control. 2019;28(6):676–7.

    Article  PubMed  Google Scholar 

  6. Lee YO, Hebert CJ, Nonnemaker JM, Kim AE. Youth tobacco product use in the United States. Pediatrics. 2015;135(3):409–15.

    Article  PubMed  Google Scholar 

  7. Villarroel MA, Cha AE, Vahratian A. Electronic cigarette use among U.S. adults, 2018. NCHS Data Brief. 2020;(365):1–8.

    Google Scholar 

  8. Wang TW, Neff LJ, Park-Lee E, Ren C, Cullen KA, King BA. E-cigarette use among middle and high school students - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1310–2.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(8):788–97.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Audrain-McGovern J, Stone MD, Barrington-Trimis J, Unger JB, Leventhal AM. Adolescent E-cigarette, Hookah, and conventional cigarette use and subsequent marijuana use. Pediatrics. 2018;142(3):e20173616.

    Article  PubMed  Google Scholar 

  11. Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019;366:l5275.

    Article  PubMed  PubMed Central  Google Scholar 

  12. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest. 2012;141(4):1110–3.

    Article  PubMed  Google Scholar 

  13. Tzortzi A, Kapetanstrataki M, Evangelopoulou V, Beghrakis P. A systematic literature review of E-cigarette-related illness and injury: not just for the respirologist. Int J Environ Res Public Health. 2020;17(7):2248.

    Article  PubMed Central  Google Scholar 

  14. Bonilla A, Blair AJ, Alamro SM, Ward RA, Feldman MB, Dutko RA, et al. Recurrent spontaneous pneumothoraces and vaping in an 18-year-old man: a case report and review of the literature. J Med Case Reports. 2019;13(1):283.

    Article  Google Scholar 

  15. Skertich NJ, Sullivan GA, Madonna M, Shah AN. Vaping is a risk factor for spontaneous pneumothorax: two cases. J Pediatr Surg Case Rep. 2019;50:101305.

    Article  Google Scholar 

  16. Sharma M, Anjum H, Bulathsinghala CP, Buch M, Surani SR. A case report of secondary spontaneous pneumothorax induced by vape. Cureus. 2019;11(11):e6067.

    PubMed  PubMed Central  Google Scholar 

  17. Hazouard E, Koninck JC, Attucci S, Fauchier-Rolland F, Brunereau L, Diot P. Pneumorachis and pneumomediastinum caused by repeated Muller’s maneuvers: complications of marijuana smoking. Ann Emerg Med. 2001;38(6):694–7.

    Article  CAS  PubMed  Google Scholar 

  18. Gaiha SM, Cheng J, Halpern-Felsher B. Association between youth smoking, electronic cigarette use, and COVID-19. J Adolesc Health. 2020;67(4):519–23.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Samet JM. Tobacco products and the risks of SARS-CoV-2 infection and COVID-19. Nicotine Tob Res. 2020;22(12 Suppl 2):S93–S5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19). J Clin Med. 2020;9(3):841.

    Article  CAS  PubMed Central  Google Scholar 

  21. Krishnasamy VP, Hallowell BD, Ko JY, Board A, Hartnett KP, Salvatore PP, et al. Update: characteristics of a Nationwide outbreak of E-cigarette, or vaping, product use-associated lung injury - United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep. 2020;69(3):90–4.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Blount BC, Karwowski MP, Shields PG, Morel-Espinosa M, Valentin-Blasini L, Gardner M, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med. 2020;382(8):697–705.

    Article  CAS  PubMed  Google Scholar 

  23. Aberegg SK, Cirulis MM, Maddock SD, Freeman A, Keenan LM, Pirozzi CS, et al. Clinical, bronchoscopic, and imaging findings of e-cigarette, or vaping, product use-associated lung injury among patients treated at an Academic Medical Center. JAMA Netw Open. 2020;3(11):e2019176.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary illness related to E-cigarette use in Illinois and Wisconsin - final report. N Engl J Med. 2020;382(10):903–16.

    Article  PubMed  Google Scholar 

  25. Kalininskiy A, Bach CT, Nacca NE, Ginsberg G, Marraffa J, Navarette KA, et al. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med. 2019;7(12):1017–26.

    Article  CAS  PubMed  Google Scholar 

  26. MacMurdo M, Lin C, Saeedan MB, Doxtader EE, Mukhopadhyay S, Arrossi V, et al. e-cigarette or vaping product use-associated lung injury: clinical, radiologic, and pathologic findings of 15 cases. Chest. 2020;157(6):e181–e7.

    Article  CAS  PubMed  Google Scholar 

  27. Zou RH, Tiberio PJ, Triantafyllou GA, Lamberty PE, Lynch MJ, Kreit JW, et al. Clinical characterization of E-cigarette, or vaping, product use-associated lung injury in 36 patients in Pittsburgh, Pennsylvania. Am J Respir Crit Care Med. 2020;201(10):1303–6.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kligerman S, Raptis C, Larsen B, Henry TS, Caporale A, Tazelaar H, et al. Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): evolving knowledge and remaining questions. Radiology. 2020;294(3):491–505.

    Article  PubMed  Google Scholar 

  29. Centers for Disease Control (CDC). 2019 lung injury surveillance primary case definition (CDC) September 18, 2019. Available from: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/assets/2019-Lung-Injury-Surveillance-Case-Definition-508.pdf.

  30. Zheng X, Guan W, Zheng J, Ye P, Liu S, Zhou J, et al. Smoking influences response to inhaled corticosteroids in patients with asthma: a meta-analysis. Curr Med Res Opin. 2012;28(11):1791–8.

    Article  CAS  PubMed  Google Scholar 

  31. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24(5):822–33.

    Article  CAS  PubMed  Google Scholar 

  32. Li D, Sundar IK, McIntosh S, Ossip DJ, Goniewicz ML, O’Connor RJ, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2. Tob Control. 2020;29(2):140–7.

    PubMed  Google Scholar 

  33. Alnajem A, Redha A, Alroumi D, Alshammasi A, Ali M, Alhussaini M, et al. Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study. Respir Res. 2020;21(1):300.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012;141(6):1400–6.

    Article  CAS  PubMed  Google Scholar 

  35. Lappas AS, Tzortzi AS, Konstantinidi EM, Teloniatis SI, Tzavara CK, Gennimata SA, et al. Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. Respirology. 2018;23(3):291–7.

    Article  PubMed  Google Scholar 

  36. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25(2):91–101.

    Article  CAS  PubMed  Google Scholar 

  37. Staudt MR, Salit J, Kaner RJ, Hollmann C, Crystal RG. Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes. Respir Res. 2018;19(1):78.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Polosa R, Cibella F, Caponnetto P, Maglia M, Prosperini U, Russo C, et al. Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep. 2017;7(1):13825.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Perez MF, Atuegwu NC, Oncken C, Mead EL, Mortensen EM. Association between electronic cigarette use and asthma in never-smokers. Ann Am Thorac Soc. 2019;16(11):1453–6.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Xie W, Kathuria H, Galiatsatos P, Blaha MJ, Hamburg NM, Robertson RM, et al. Association of electronic cigarette use with incident respiratory conditions among US adults from 2013 to 2018. JAMA Netw Open. 2020;3(11):e2020816.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Wills TA, Soneji SS, Choi K, Jaspers I, Tam EK. E-cigarette use and respiratory disorder: an integrative review of converging evidence from epidemiological and laboratory studies. Eur Respir J. 2021;57:1901815.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Wills TA, Choi K, Pagano I. E-cigarette use associated with asthma independent of cigarette smoking and marijuana in a 2017 national sample of adolescents. J Adolesc Health. 2020;67(4):524–30.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Schweitzer RJ, Wills TA, Tam E, Pagano I, Choi K. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med. 2017;105:226–31.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Polosa R, Morjaria JB, Caponnetto P, Prosperini U, Russo C, Pennisi A, et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res. 2016;17(1):166.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Campagna D, Amaradio MD, Sands MF, Polosa R. Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping. Pneumonia (Nathan). 2016;8:4.

    Article  Google Scholar 

  46. Canistro D, Vivarelli F, Cirillo S, Babot Marquillas C, Buschini A, Lazzaretti M, et al. E-cigarettes induce toxicological effects that can raise the cancer risk. Sci Rep. 2017;7(1):2028.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Rankin GD, Wingfors H, Uski O, Hedman L, Ekstrand-Hammarstrom B, Bosson J, et al. The toxic potential of a fourth-generation E-cigarette on human lung cell lines and tissue explants. J Appl Toxicol. 2019;39(8):1143–54.

    Article  CAS  PubMed  Google Scholar 

  48. Park S, Walser T, Tran L, Perdomo C, Wang T, Hong L, et al. The biological impact of e-cigarettes on airway epithelial cell transformation and gene expression. J Thorac Oncol. 2016;11(25):S35–6.

    Article  Google Scholar 

  49. Flach S, Maniam P, Manickavasagam J. E-cigarettes and head and neck cancers: a systematic review of the current literature. Clin Otolaryngol. 2019;44(5):749–56.

    Article  PubMed  Google Scholar 

  50. Li L, Lin Y, Xia T, Zhu Y. Effects of electronic cigarettes on indoor air quality and health. Annu Rev Public Health. 2020;41:363–80.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction. Am J Prev Med. 2018;55(4):455–61.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Tzortzi A, Teloniatis SI, Matiampa G, Bakelas G, Vyzikidou VK, Vardavas C, et al. Passive exposure to e-cigarette emissions: immediate respiratory effects. Tob Prev Cessat. 2018;4:18.

    PubMed  PubMed Central  Google Scholar 

  53. Bayly JE, Bernat D, Porter L, Choi K. Secondhand exposure to aerosols from electronic nicotine delivery systems and asthma exacerbations among youth with asthma. Chest. 2019;155(1):88–93.

    Article  PubMed  Google Scholar 

  54. UNODC (United Nations Office on Drugs and Crime). World Drug Report 2020. Vienna: United Nations 2020.

    Google Scholar 

  55. SAMHSA (Substance Abuse and Mental Health Services Administration). Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020.

    Google Scholar 

  56. Owen KP, Sutter ME, Albertson TE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol. 2014;46(1):65–81.

    Article  CAS  PubMed  Google Scholar 

  57. Graves BM, Johnson TJ, Nishida RT, Dias RP, Savareear B, Harynuk JJ, et al. Comprehensive characterization of mainstream marijuana and tobacco smoke. Sci Rep. 2020;10(1):7160.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Tashkin DP, Gliederer F, Rose J, Change P, Hui KK, Yu JL, et al. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC. Pharmacol Biochem Behav. 1991;40(3):651–6.

    Article  CAS  PubMed  Google Scholar 

  59. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318(6):347–51.

    Article  CAS  PubMed  Google Scholar 

  60. Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med. 2005;20(1):33–7.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007;167(3):221–8.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Miller WE, Spiekerman RE, Hepper NG. Pneumomediastinum resulting from performing Valsalva maneuvers during marihuana smoking. Chest. 1972;62(2):233–4.

    Article  CAS  PubMed  Google Scholar 

  63. Luque MA 3rd, Cavallaro DL, Torres M, Emmanual P, Hillman JV. Pneumomediastinum, pneumothorax, and subcutaneous emphysema after alternate cocaine inhalation and marijuana smoking. Pediatr Emerg Care. 1987;3(2):107–9.

    Article  PubMed  Google Scholar 

  64. Goodyear K, Laws D, Turner J. Bilateral spontaneous pneumothorax in a cannabis smoker. J R Soc Med. 2004;97(9):435–6.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Roth MD, Baldwin GC, Tashkin DP. Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids. 2002;121(1–2):229–39.

    Article  CAS  PubMed  Google Scholar 

  66. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324(10):654–62.

    Article  CAS  PubMed  Google Scholar 

  67. Chusid MJ, Gelfand JA, Nutter C, Fauci AS. Letter: pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease. Ann Intern Med. 1975;82(5):682–3.

    Article  CAS  PubMed  Google Scholar 

  68. Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. Chest. 1988;94(2):432–3.

    Article  CAS  PubMed  Google Scholar 

  69. Cescon DW, Page AV, Richardson S, Moore MJ, Boerner S, Gold WL. Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer. J Clin Oncol. 2008;26(13):2214–5.

    Article  PubMed  Google Scholar 

  70. Marks WH, Florence L, Lieberman J, Chapman P, Howard D, Roberts P, et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation. 1996;61(12):1771–4.

    Article  CAS  PubMed  Google Scholar 

  71. Kagen SL, Kurup VP, Sohnle PG, Fink JN. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol. 1983;71(4):389–93.

    Article  CAS  PubMed  Google Scholar 

  72. Lorenz DR, Uno H, Wolinsky SM, Gabuzda D. Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study. EClinicalMedicine. 2019;7:55–64.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Caiaffa WT, Vlahov D, Graham NM, Astemborski J, Solomon L, Nelson KE, et al. Drug smoking, pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1493–8.

    Article  CAS  PubMed  Google Scholar 

  74. Quint JJ, Tashkin DP, McKay HS, Plankey MW, Stosor V, Friedman MR, et al. Marijuana use and pneumonia risk in a cohort of HIV-infected and HIV-uninfected men. Ann Epidemiol. 2020;52:64–70 e2.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Pletcher MJ, Vittinghoff E, Kalhan R, Richman J, Safford M, Sidney S, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307(2):173–81.

    Article  CAS  PubMed  Google Scholar 

  76. Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Ann Am Thorac Soc. 2015;12(2):135–41.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Hancox RJ, Poulton R, Ely M, Welch D, Taylor DR, McLachlan CR, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42–7.

    Article  CAS  PubMed  Google Scholar 

  78. Morris MA, Jacobson SR, Kinney GL, Tashkin DP, Woodruff PG, Hoffman EA, et al. Marijuana use associations with pulmonary symptoms and function in tobacco smokers enrolled in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS). Chronic Obstr Pulm Dis. 2018;5(1):46–56.

    PubMed  PubMed Central  Google Scholar 

  79. Macleod J, Robertson R, Copeland L, McKenzie J, Elton R, Reid P. Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population. Br J Gen Pract. 2015;65(631):e89–95.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Tan WC, Bourbeau J, Aaron SD, Hogg JC, Maltais F, Hernandez P, et al. The effects of marijuana smoking on lung function in older people. Eur Respir J. 2019;54(6):1900826.

    Article  PubMed  Google Scholar 

  81. Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62(12):1058–63.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Tan WC, Lo C, Jong A, Xing L, Fitzgerald MJ, Vollmer WM, et al. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ. 2009;180(8):814–20.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Johnson MK, Smith RP, Morrison D, Laszlo G, White RJ. Large lung bullae in marijuana smokers. Thorax. 2000;55(4):340–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Beshay M, Kaiser H, Niedhart D, Reymond MA, Schmid RA. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur J Cardiothorac Surg. 2007;32(6):834–8.

    Article  PubMed  Google Scholar 

  85. Hii SW, Tam JD, Thompson BR, Naughton MT. Bullous lung disease due to marijuana. Respirology. 2008;13(1):122–7.

    Article  PubMed  Google Scholar 

  86. Mishra R, Patel R, Khaja M. Cannabis-induced bullous lung disease leading to pneumothorax: case report and literature review. Medicine (Baltimore). 2017;96(19):e6917.

    Article  Google Scholar 

  87. Phan TD, Lau KK, Li X. Lung bullae and pulmonary fibrosis associated with marijuana smoking. Australas Radiol. 2005;49(5):411–4.

    Article  CAS  PubMed  Google Scholar 

  88. Ghasemiesfe M, Ravi D, Vali M, Korenstein D, Arjomandi M, Frank J, et al. Marijuana use, respiratory symptoms, and pulmonary function: a systematic review and meta-analysis. Ann Intern Med. 2018;169(2):106–15.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med. 1998;157(3 Pt 1):928–37.

    Article  CAS  PubMed  Google Scholar 

  90. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112(2):319–26.

    Article  CAS  PubMed  Google Scholar 

  91. Tashkin DP, Simmons MS, Tseng CH. Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD. 2012;9(4):367–74.

    Article  PubMed  Google Scholar 

  92. Hancox RJ, Shin HH, Gray AR, Poulton R, Sears MR. Effects of quitting cannabis on respiratory symptoms. Eur Respir J. 2015;46(1):80–7.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Ghasemiesfe M, Barrow B, Leonard S, Keyhani S, Korenstein D. Association between marijuana use and risk of cancer: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(11):e1916318.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Jett J, Stone E, Warren G, Cummings KM. Cannabis use, lung cancer, and related issues. J Thorac Oncol. 2018;13(4):480–7.

    Article  PubMed  Google Scholar 

  95. Tashkin DP. Marijuana and lung disease. Chest. 2018;154(3):653–63.

    Article  PubMed  Google Scholar 

  96. Ribeiro LI, Ind PW. Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review. NPJ Prim Care Respir Med. 2016;26:16071.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Haddad L, Kelly DL, Weglicki LS, Barnett TE, Ferrell AV, Ghadban R. A systematic review of effects of waterpipe smoking on cardiovascular and respiratory health outcomes. Tob Use Insights. 2016;9:13–28.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco product use among adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736–42.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Gentzke AS, Wang TW, Jamal A, Park-Lee E, Ren C, Cullen KA, et al. Tobacco product use among middle and high school students - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1881–8.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Schulenberg J, Johnston L, O’Malley P, Bachman J, Miech R, Patrick M. Monitoring the Future National Survey on Drug Use 1975-2018: Volume II, College Students and Adults Ages 19–60. 2019 [cited Jan 12, 2021]. Ann Arbor: Institute for Social Research, The University of Michigan, [cited Jan 12, 2021]. Available from: http://monitoringthefuture.org/pubs.html#monographs.

  101. Villanti AC, Johnson AL, Glasser AM, Rose SW, Ambrose BK, Conway KP, et al. Association of flavored tobacco use with tobacco initiation and subsequent use among US youth and adults, 2013–2015. JAMA Netw Open. 2019;2(10):e1913804.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Soneji S, Knutzen KE, Gravely S, Elton-Marshall T, Sargent J, Lambert E, et al. Transitions in frequency of hookah smoking among youth and adults: findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study, 2013–15. Addiction. 2021;116:936–48.

    Article  PubMed  Google Scholar 

  103. Waziry R, Jawad M, Ballout RA, Al Akel M, Akl EA. The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis. Int J Epidemiol. 2017;46(1):32–43.

    PubMed  Google Scholar 

  104. Raad D, Gaddam S, Schunemann HJ, Irani J, Abou Jaoude P, Honeine R, et al. Effects of water-pipe smoking on lung function: a systematic review and meta-analysis. Chest. 2011;139(4):764–74.

    Article  PubMed  Google Scholar 

  105. Bahtouee M, Maleki N, Nekouee F. The prevalence of chronic obstructive pulmonary disease in hookah smokers. Chron Respir Dis. 2018;15(2):165–72.

    Article  PubMed  Google Scholar 

  106. Morovatdar N, Poorzand H, Yones Bondarsahebi YB, Hozhabrossadati SA, Montazeri S, Sahebkar A. Water pipe tobacco smoking and risk of Coronary Artery Disease: a systematic review and meta-analyses. Curr Mol Pharmacol. 2020.

    Google Scholar 

  107. Sibai AM, Tohme RA, Almedawar MM, Itani T, Yassine SI, Nohra EA, et al. Lifetime cumulative exposure to waterpipe smoking is associated with coronary artery disease. Atherosclerosis. 2014;234(2):454–60.

    Article  CAS  PubMed  Google Scholar 

  108. Mamtani R, Cheema S, Sheikh J, Al Mulla A, Lowenfels A, Maisonneuve P. Cancer risk in waterpipe smokers: a meta-analysis. Int J Public Health. 2017;62(1):73–83.

    Article  PubMed  Google Scholar 

  109. Montazeri Z, Nyiraneza C, El-Katerji H, Little J. Waterpipe smoking and cancer: systematic review and meta-analysis. Tob Control. 2017;26(1):92–7.

    Article  PubMed  Google Scholar 

  110. Aljadani RH, Algabbani AM, Alamir JA, Alqahtani AS, BinDhim NF. Waterpipe tobacco chemical content, microbial contamination, and genotoxic effects: a systematic review. Int J Toxicol. 2020;39(3):256–62.

    Article  PubMed  Google Scholar 

  111. Aragon A, Velasco MJ, Gavilan AM, Fernandez-Garcia A, Sanz JC. Mumps virus outbreak related to a water pipe (narghile) shared smoking. Enferm Infecc Microbiol Clin. 2020.

    Google Scholar 

  112. Munckhof WJ, Konstantinos A, Wamsley M, Mortlock M, Gilpin C. A cluster of tuberculosis associated with use of a marijuana water pipe. Int J Tuberc Lung Dis. 2003;7(9):860–5.

    CAS  PubMed  Google Scholar 

  113. Aboaziza E, Eissenberg T. Waterpipe tobacco smoking: what is the evidence that it supports nicotine/tobacco dependence? Tob Control. 2015;24 Suppl 1:i44–53.

    Article  PubMed  Google Scholar 

  114. Neergaard J, Singh P, Job J, Montgomery S. Waterpipe smoking and nicotine exposure: a review of the current evidence. Nicotine Tob Res. 2007;9(10):987–94.

    Article  CAS  PubMed  Google Scholar 

  115. Ebrahimi Kalan M, Behaleh R, DiFranza JR, Bursac Z, Ben Taleb Z, Tleis M, et al. Natural course of nicotine dependence among adolescent waterpipe and cigarette smokers. J Adolesc Health. 2020;67(6):859–67.

    Article  PubMed  Google Scholar 

  116. Al Oweini D, Jawad M, Akl EA. The association of waterpipe tobacco smoking with later initiation of cigarette smoking: a systematic review and meta-analysis exploring the gateway theory. Tob Control. 2019.

    Google Scholar 

  117. Travers MJ, Rivard C, Sharma E, Retzky S, Yucesoy B, Goniewicz ML, et al. Biomarkers of exposure among USA adult hookah users: results from wave 1 of the Population Assessment of Tobacco and Health (PATH) Study (2013–2014). Int J Environ Res Public Health. 2020;17(17):6403.

    Article  CAS  PubMed Central  Google Scholar 

  118. Eissenberg T, Shihadeh A. Waterpipe tobacco and cigarette smoking: direct comparison of toxicant exposure. Am J Prev Med. 2009;37(6):518–23.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Shihadeh A, Eissenberg T, Rammah M, Salman R, Jaroudi E, El-Sabban M. Comparison of tobacco-containing and tobacco-free waterpipe products: effects on human alveolar cells. Nicotine Tob Res. 2014;16(4):496–9.

    Article  PubMed  Google Scholar 

  120. Khabour OF, Alzoubi KH, Al-Sawalha N, Ahmad MB, Shihadeh A, Eissenberg T. The effect of chronic exposure to waterpipe tobacco smoke on airway inflammation in mice. Life Sci. 2018;200:110–4.

    Article  CAS  PubMed  Google Scholar 

  121. Heydari G, Taghizdeh F, Fazlzadeh M, Jafari AJ, Asadgol Z, Mehrizi EA, et al. Levels and health risk assessments of particulate matters (PM2.5 and PM10) in indoor/outdoor air of waterpipe cafes in Tehran, Iran. Environ Sci Pollut Res Int. 2019;26(7):7205–15.

    Article  CAS  PubMed  Google Scholar 

  122. Zhou S, Behrooz L, Weitzman M, Pan G, Vilcassim R, Mirowsky JE, et al. Secondhand hookah smoke: an occupational hazard for hookah bar employees. Tob Control. 2017;26(1):40–5.

    Article  PubMed  Google Scholar 

  123. Martinasek MP, Calvanese AV, Lipski BK. A naturalistic study of carbon monoxide, heart rate, oxygen saturation, and perfusion index in hookah lounge patrons. Respir Care. 2021;66:269–74.

    Article  PubMed  Google Scholar 

  124. Inyang NA, Chang JT, Wang B. National Estimates of hospital emergency department visits due to acute injuries associated with hookah smoking, United States, 2011–2019. Inj Epidemiol. 2020;7(1):41.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Rostron BL, Wang B, Liu ST. Waterpipe or hookah-related poisoning events among U.S. adolescents and young adults. J Adolesc Health. 2019;64(6):800–3.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Nguyen V, Salama M, Fernandez D, Sperling JD, Regina A, Rivera R, et al. Comparison between carbon monoxide poisoning from hookah smoking versus other sources. Clin Toxicol (Phila). 2020;58(12):1320–5.

    Article  CAS  Google Scholar 

  127. Eichhorn L, Michaelis D, Kemmerer M, Juttner B, Tetzlaff K. Carbon monoxide poisoning from waterpipe smoking: a retrospective cohort study. Clin Toxicol (Phila). 2018;56(4):264–72.

    Article  CAS  Google Scholar 

  128. Veen M. Carbon monoxide poisoning caused by water pipe smoking: a case series. J Emerg Med. 2016;51(3):e41–4.

    Article  PubMed  Google Scholar 

  129. Shaikh RB, Vijayaraghavan N, Sulaiman AS, Kazi S, Shafi MS. The acute effects of waterpipe smoking on the cardiovascular and respiratory systems. J Prev Med Hyg. 2008;49(3):101–7.

    CAS  PubMed  Google Scholar 

  130. Hakim F, Hellou E, Goldbart A, Katz R, Bentur Y, Bentur L. The acute effects of water-pipe smoking on the cardiorespiratory system. Chest. 2011;139(4):775–81.

    Article  PubMed  Google Scholar 

  131. Hawari FI, Obeidat NA, Ayub H, Ghonimat I, Eissenberg T, Dawahrah S, et al. The acute effects of waterpipe smoking on lung function and exercise capacity in a pilot study of healthy participants. Inhal Toxicol. 2013;25(9):492–7.

    Article  CAS  PubMed  Google Scholar 

  132. Hawari FI, Obeidat NA, Abu Alhalawa M, Al-Busaidi Z, Amara B, Baddar S, et al. Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers. Int J Chron Obstruct Pulmon Dis. 2019;14:1813–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Strulovici-Barel Y, Shaykhiev R, Salit J, Deeb RS, Krause A, Kaner RJ, et al. Pulmonary abnormalities in young, light-use waterpipe (hookah) smokers. Am J Respir Crit Care Med. 2016;194(5):587–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Kang M, Raj V, Berman AR. A man in his 20s with diffuse lung opacities and acute respiratory failure after hookah smoking. Chest. 2016;150(6):e175–e8.

    Article  PubMed  Google Scholar 

  135. Mager S, Struss M, Wollsching-Strobel M, Karagiannidis C. Acute eosinophilic pneumonia (AEP) after hookah smoking. Pneumologie. 2020;74(4):230–3.

    CAS  PubMed  Google Scholar 

  136. Shekhar S, Hannah-Shmouni F. Hookah smoking and COVID-19: call for action. CMAJ. 2020;192(17):E462.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Alagaili AN, Briese T, Amor NMS, Mohammed OB, Lipkin WI. Waterpipe smoking as a public health risk: potential risk for transmission of MERS-CoV. Saudi J Biol Sci. 2019;26(5):938–41.

    Article  PubMed  Google Scholar 

  138. Ben Saad H, Khemis M, Bougmiza I, Prefaut C, Aouina H, Mrizek N, et al. Spirometric profile of narghile smokers. Rev Mal Respir. 2011;28(7):e39–51.

    Article  CAS  PubMed  Google Scholar 

  139. Rammah M, Dandachi F, Salman R, Shihadeh A, El-Sabban M. In vitro cytotoxicity and mutagenicity of mainstream waterpipe smoke and its functional consequences on alveolar type II derived cells. Toxicol Lett. 2012;211(3):220–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Al Ali R, Rastam S, Ibrahim I, Bazzi A, Fayad S, Shihadeh AL, et al. A comparative study of systemic carcinogen exposure in waterpipe smokers, cigarette smokers and non-smokers. Tob Control. 2015;24(2):125–7.

    Article  PubMed  Google Scholar 

  141. Hatsukami DK, Fischman MW. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA. 1996;276(19):1580–8.

    Article  CAS  PubMed  Google Scholar 

  142. Tashkin DP, Khalsa ME, Gorelick D, Chang P, Simmons MS, Coulson AH, et al. Pulmonary status of habitual cocaine smokers. Am Rev Respir Dis. 1992;145(1):92–100.

    Article  CAS  PubMed  Google Scholar 

  143. Milroy CM, Parai JL. The histopathology of drugs of abuse. Histopathology. 2011;59(4):579–93.

    Article  PubMed  Google Scholar 

  144. Forrester JM, Steele AW, Waldron JA, Parsons PE. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis. 1990;142(2):462–7.

    Article  CAS  PubMed  Google Scholar 

  145. Kissner DG, Lawrence WD, Selis JE, Flint A. Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis. 1987;136(5):1250–2.

    Article  CAS  PubMed  Google Scholar 

  146. Murray RJ, Albin RJ, Mergner W, Criner GJ. Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest. 1988;93(2):427–9.

    Article  CAS  PubMed  Google Scholar 

  147. Jimenez-Zarazua O, Lopez-Garcia JA, Arce-Negrete LR, Velez-Ramirez LN, Casimiro-Guzman L, Mondragon JD. Alveolar hemorrhage associated with cocaine consumption. Heart Lung. 2018;47(5):525–30.

    Article  PubMed  Google Scholar 

  148. Bailey ME, Fraire AE, Greenberg SD, Barnard J, Cagle PT. Pulmonary histopathology in cocaine abusers. Hum Pathol. 1994;25(2):203–7.

    Article  CAS  PubMed  Google Scholar 

  149. Lee KC, Ladizinski B, Federman DG. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012;87(6):581–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  150. McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011;6(12):2799–805.

    Article  PubMed  PubMed Central  Google Scholar 

  151. Pendergraft WF 3rd, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol. 2014;26(1):42–9.

    Article  CAS  PubMed  Google Scholar 

  152. Trimarchi M, Bertazzoni G, Bussi M. Cocaine induced midline destructive lesions. Rhinology. 2014;52(2):104–11.

    Article  CAS  PubMed  Google Scholar 

  153. de Almeida RR, de Souza LS, Mancano AD, Souza AS Jr, Irion KL, Nobre LF, et al. High-resolution computed tomographic findings of cocaine-induced pulmonary disease: a state of the art review. Lung. 2014;192(2):225–33.

    Article  PubMed  Google Scholar 

  154. Rubin RB, Neugarten J. Cocaine-associated asthma. Am J Med. 1990;88(4):438–9.

    Article  CAS  PubMed  Google Scholar 

  155. Blanksma CJ, Brand HS. Cocaine abuse: orofacial manifestations and implications for dental treatment. Int Dent J. 2005;55(6):365–9.

    Article  CAS  PubMed  Google Scholar 

  156. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  157. Arnett EN, Battle WE, Russo JV, Roberts WC. Intravenous injection of talc-containing drugs intended for oral use. A cause of pulmonary granulomatosis and pulmonary hypertension. Am J Med. 1976;60(5):711–8.

    Article  CAS  PubMed  Google Scholar 

  158. Murray RJ, Smialek JE, Golle M, Albin RJ. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest. 1989;96(5):1050–3.

    Article  CAS  PubMed  Google Scholar 

  159. Kleerup EC, Wong M, Marques-Magallanes JA, Goldman MD, Tashkin DP. Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers. Chest. 1997;111(1):30–5.

    Article  CAS  PubMed  Google Scholar 

  160. Alzghoul BN, Abualsuod A, Alqam B, Innabi A, Palagiri DR, Gheith Z, et al. Cocaine use and pulmonary hypertension. Am J Cardiol. 2020;125(2):282–8.

    Article  CAS  PubMed  Google Scholar 

  161. Tseng W, Sutter ME, Albertson TE. Stimulants and the lung: review of literature. Clin Rev Allergy Immunol. 2014;46(1):82–100.

    Article  CAS  PubMed  Google Scholar 

  162. Derlet RW, Rice P, Horowitz BZ, Lord RV. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989;7(2):157–61.

    Article  CAS  PubMed  Google Scholar 

  163. Nestor TA, Tamamoto WI, Kam TH, Schultz T. Crystal methamphetamine-induced acute pulmonary edema: a case report. Hawaii Med J. 1989;48(11):457–8, 60.

    CAS  PubMed  Google Scholar 

  164. Lin SS, Chen YC, Chang YL, Yeh DY, Lin CC. Crystal amphetamine smoking-induced acute eosinophilic pneumonia and diffuse alveolar damage: a case report and literature review. Chin J Physiol. 2014;57(5):295–8.

    Article  PubMed  Google Scholar 

  165. Yeh PS, Yuan A, Yu CJ, Kuo SH, Luh KT, Yang PC. Acute respiratory distress syndrome in a woman with heroin and methamphetamine misuse. J Formos Med Assoc. 2001;100(8):553–6.

    CAS  PubMed  Google Scholar 

  166. McCarthy E, McClain E. Methamphetamine-induced lung injury. Eur J Case Rep Intern Med. 2019;6(6):001067.

    PubMed  PubMed Central  Google Scholar 

  167. Tsai H, Lee J, Hedlin H, Zamanian RT, de Jesus Perez VA. Methamphetamine use association with pulmonary diseases: a retrospective investigation of hospital discharges in California from 2005 to 2011. ERJ Open Res. 2019;5(4):00017-2019.

    Article  PubMed  PubMed Central  Google Scholar 

  168. Wells SM, Buford MC, Braseth SN, Hutchison JD, Holian A. Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice. Inhal Toxicol. 2008;20(9):829–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  169. Kolaitis NA, Zamanian RT, de Jesus Perez VA, Badesch DB, Benza RL, Burger CD, et al. Clinical differences and outcomes between methamphetamine-associated and idiopathic pulmonary arterial hypertension in the PHAR. Ann Am Thorac Soc. 2021;18:613–22.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Zamanian RT, Hedlin H, Greuenwald P, Wilson DM, Segal JI, Jorden M, et al. Features and outcomes of methamphetamine-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2018;197(6):788–800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  171. Ramirez RL 3rd, Perez VJ, Zamanian RT. Methamphetamine and the risk of pulmonary arterial hypertension. Curr Opin Pulm Med. 2018;24(5):416–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  172. Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(50-51):1445–52.

    Article  PubMed  Google Scholar 

  173. Hines LA, Lynskey M, Morley KI, Griffiths P, Gossop M, Powis B, et al. The relationship between initial route of heroin administration and speed of transition to daily heroin use. Drug Alcohol Rev. 2017;36(5):633–8.

    Article  PubMed  Google Scholar 

  174. Strang J, Griffiths P, Powis B, Gossop M. First use of heroin: changes in route of administration over time. BMJ. 1992;304(6836):1222–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  175. Cruz R, Davis M, O’Neil H, Tamarin F, Brandstetter RD, Karetzky M. Pulmonary manifestations of inhaled street drugs. Heart Lung. 1998;27(5):297–305; quiz 6-7.

    Article  CAS  PubMed  Google Scholar 

  176. del los Santos-Sastre S, Capote-Gil F, Gonzales-Castro A. Airway obstruction and heroin inhalation. Lancet. 1986;2(8516):1158.

    Article  Google Scholar 

  177. Nightingale R, Mortimer K, Giorgi E, Walker PP, Stolbrink M, Byrne T, et al. Screening heroin smokers attending community drug clinics for change in lung function: a cohort study. Chest. 2020;157(3):558–65.

    Article  PubMed  Google Scholar 

  178. Duberstein JL, Kaufman DM. A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med. 1971;51(6):704–14.

    Article  CAS  PubMed  Google Scholar 

  179. Prowse SJ, Lima T, Irion KL, Burhan H, Hochhegger B, Marchiori E. Valsalva manoeuvre effect on distribution of lung damage in heroin inhalation. Br J Radiol. 2011;84(1006):e200–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  180. Schachter EN, Basta W. Bronchiectasis following heroin overdose. A report of two cases. Chest. 1973;63(3):363–6.

    Article  CAS  PubMed  Google Scholar 

  181. Brander PE, Tukiainen P. Acute eosinophilic pneumonia in a heroin smoker. Eur Respir J. 1993;6(5):750–2.

    CAS  PubMed  Google Scholar 

  182. Hulin J, Brodie A, Stevens J, Mitchell C. Prevalence of respiratory conditions among people who use illicit opioids: a systematic review. Addiction. 2020;115(5):832–49.

    Article  PubMed  Google Scholar 

  183. Walker PP, Thwaite E, Amin S, Curtis JM, Calverley PMA. The association between heroin inhalation and early onset emphysema. Chest. 2015;148(5):1156–63.

    Article  PubMed  Google Scholar 

  184. Zhou Y, Liu Y. Recent trends in current asthma prevalence among US adults, 2009–2018. J Allergy Clin Immunol Pract. 2020;8(8):2814–6.

    Article  PubMed  Google Scholar 

  185. Krantz AJ, Hershow RC, Prachand N, Hayden DM, Franklin C, Hryhorczuk DO. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest. 2003;123(2):510–7.

    Article  PubMed  Google Scholar 

  186. Cygan J, Trunsky M, Corbridge T. Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest. 2000;117(1):272–5.

    Article  CAS  PubMed  Google Scholar 

  187. Levine M, Iliescu ME, Margellos-Anast H, Estarziau M, Ansell DA. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest. 2005;128(4):1951–7.

    Article  PubMed  Google Scholar 

  188. Hughes S, Calverley PM. Heroin inhalation and asthma. BMJ. 1988;297(6662):1511–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  189. Withington DE, Patrick JA, Reynolds F. Histamine release by morphine and diamorphine in man. Anaesthesia. 1993;48(1):26–9.

    Article  CAS  PubMed  Google Scholar 

  190. Rook EJ, van Zanten AP, Van den Brink W, van Ree JM, Beijnen JH. Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. Drug Alcohol Depend. 2006;85(3):185–90.

    Article  CAS  PubMed  Google Scholar 

  191. Ruzycki S, Yarema M, Dunham M, Sadrzadeh H, Tremblay A. Intranasal fentanyl intoxication leading to diffuse alveolar hemorrhage. J Med Toxicol. 2016;12(2):185–8.

    Article  CAS  PubMed  Google Scholar 

  192. Cole JB, Dunbar JF, McIntire SA, Regelmann WE, Slusher TM. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage. Pediatrics. 2015;135(3):e740–3.

    Article  PubMed  Google Scholar 

  193. Chapman E, Leipsic J, Satkunam N, Churg A. Pulmonary alveolar proteinosis as a reaction to fentanyl patch smoke. Chest. 2012;141(5):1321–3.

    Article  PubMed  Google Scholar 

  194. SAMHSA (Substance Abuse and Mental Health Services Administration). Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration: HHS Publication No. (SMA) 13-4760, DAWN Series D-39; 2013.

    Google Scholar 

  195. Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract. 2011;6(1):18–31.

    PubMed  PubMed Central  Google Scholar 

  196. Lipari RN. Understanding adolescent inhalant use. The CBHSQ report. Rockville (MD); 2013. p. 1–7.

    Google Scholar 

  197. Ramon MF, Ballesteros S, Martinez-Arrieta R, Torrecilla JM, Cabrera J. Volatile substance and other drug abuse inhalation in Spain. J Toxicol Clin Toxicol. 2003;41(7):931–6.

    Article  CAS  PubMed  Google Scholar 

  198. Brouette T, Anton R. Clinical review of inhalants. Am J Addict. 2001;10(1):79–94.

    Article  CAS  PubMed  Google Scholar 

  199. Buker HS, Demir E, Yuncu Z, Gulen F, Midyat L, Tanac R. Effects of volatile substance abuse on the respiratory system in adolescents. Multidiscip Respir Med. 2011;6(3):161–8.

    Article  PubMed  PubMed Central  Google Scholar 

  200. Schikler KN, Lane EE, Seitz K, Collins WM. Solvent abuse associated pulmonary abnormalities. Adv Alcohol Subst Abuse. 1984;3(3):75–81.

    Article  CAS  PubMed  Google Scholar 

  201. Han B, Gfroerer JC, Colliver JD. Associations between duration of illicit drug use and health conditions: results from the 2005–2007 national surveys on drug use and health. Ann Epidemiol. 2010;20(4):289–97.

    Article  PubMed  Google Scholar 

  202. Ott MG. Occupational asthma, lung function decrement, and toluene diisocyanate (TDI) exposure: a critical review of exposure-response relationships. Appl Occup Environ Hyg. 2002;17(12):891–901.

    Article  CAS  PubMed  Google Scholar 

  203. Kobayashi K, Suzuki M, Yamamoto S, Ueno K, Miyawaki E, Takazawa I, et al. Early-onset, severe chronic obstructive pulmonary disease with pulmonary hypertension that was likely induced by toluene exposure. Intern Med. 2017;56(17):2329–34.

    Article  PubMed  PubMed Central  Google Scholar 

  204. Schloneger M, Stull A, Singer JI. Inhalant abuse: a case of hemoptysis associated with halogenated hydrocarbons abuse. Pediatr Emerg Care. 2009;25(11):754–7.

    Article  PubMed  Google Scholar 

  205. Bombassei GJ, Kaplan AA. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture’s syndrome). Am J Ind Med. 1992;21(2):141–53.

    Article  CAS  PubMed  Google Scholar 

  206. Kurtzman TL, Otsuka KN, Wahl RA. Inhalant abuse by adolescents. J Adolesc Health. 2001;28(3):170–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO, USA

    Anne E. Reihman, Fernando Holguin & Sunita Sharma

Authors
  1. Anne E. Reihman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando Holguin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sunita Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunita Sharma .

Editor information

Editors and Affiliations

  1. Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA

    Sumita B. Khatri

  2. Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA

    Emily J. Pennington

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reihman, A.E., Holguin, F., Sharma, S. (2022). Acute and Chronic Lung Disease from Recreational Inhalants. In: Khatri, S.B., Pennington, E.J. (eds) Lung Health and the Exposome . Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-90185-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-90185-1_7

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-90184-4

  • Online ISBN: 978-3-030-90185-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation